Entrada Therapeutics, Inc. (TRDA) Ownership

$7.90

north_east
$0.05 (0.64%)
Day's range
$7.54
Day's range
$8.14

Entrada Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 02/14/2025 4.87 M $84.13 M   0.00% 11.98%
5AM VENTURE MANAGEMENT, LLC 02/14/2025 4.41 M $76.22 M   0.00% 10.85%
MPM ASSET MANAGEMENT LLC 02/14/2025 4.38 M $75.75 M   -1.01% 10.78%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 2.90 M $50.19 M   -4.81% 7.15%
JANUS HENDERSON GROUP PLC 02/14/2025 2.08 M $36.01 M   21.56% 5.12%
BLACKROCK, INC. 02/07/2025 1.97 M $34.14 M   8.32% 4.86%
VANGUARD GROUP INC 02/11/2025 1.46 M $25.32 M   19.71% 3.60%
FMR LLC 02/13/2025 1.40 M $24.20 M   -19.71% 3.45%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 1.03 M $17.84 M   0.24% 2.54%
STEPSTONE GROUP LP 02/13/2025 761,277 $13.16 M   0.00% 1.87%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 584,955 $10.11 M   0.00% 1.44%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 573,891 $9.93 M   -0.44% 1.41%
STATE STREET CORP 02/14/2025 504,979 $8.73 M   7.53% 1.24%
NORTHERN TRUST CORP 02/14/2025 318,177 $5.50 M   28.46% 0.78%
GOLDMAN SACHS GROUP INC 02/11/2025 285,272 $4.93 M   237.74% 0.70%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 222,520 $3.85 M   123.20% 0.55%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 217,006 $3.75 M   127.45% 0.53%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/14/2025 212,717 $3.68 M   5.41% 0.52%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 197,127 $3.41 M   5.99% 0.49%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 166,200 $2.87 M   77.19% 0.41%
MOORE CAPITAL MANAGEMENT, LP 02/14/2025 105,000 $1.82 M   0.00% 0.26%
BANK OF NEW YORK MELLON CORP 02/04/2025 101,358 $1.75 M   -3.44% 0.25%
FEDERATED HERMES, INC. 02/13/2025 99,814 $1.73 M   3,104.30% 0.25%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 87,506 $1.51 M   -32.62% 0.22%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 85,621 $1.48 M   -38.23% 0.21%
MORGAN STANLEY 02/14/2025 81,873 $1.42 M   -12.22% 0.20%
FIRST TRUST ADVISORS LP 02/13/2025 73,749 $1.28 M   -9.56% 0.18%
CITADEL ADVISORS LLC 02/14/2025 70,669 $1.22 M   -19.90% 0.17%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 02/12/2025 67,384 $1.17 M   -2.90% 0.17%
AMERICAN CENTURY COMPANIES INC 02/11/2025 59,710 $1.03 M   17.71% 0.15%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 56,557 $977,871   -0.52% 0.14%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 55,517 $959,000   40.76% 0.14%
LPL FINANCIAL LLC 02/11/2025 55,154 $953,613   12.92% 0.14%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 54,979 $950,587   39.30% 0.14%
UBS GROUP AG 02/14/2025 53,091 $917,943   112.44% 0.13%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 51,491 $890,000   -21.42% 0.13%
BARCLAYS PLC 02/13/2025 51,365 $887,000   13.87% 0.13%
NAN FUNG GROUP HOLDINGS LTD 02/13/2025 49,082 $848,628   0.00% 0.12%
TD ASSET MANAGEMENT INC 02/11/2025 47,788 $826,255   0.00% 0.12%
AMERIPRISE FINANCIAL INC 02/14/2025 40,624 $702,389   6.61% 0.10%
MARTINGALE ASSET MANAGEMENT L P 02/13/2025 38,623 $667,793   1.85% 0.10%
RHUMBLINE ADVISERS 01/30/2025 36,731 $635,069   1.19% 0.09%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 35,750 $618,118   152.54% 0.09%
BANK OF AMERICA CORP /DE/ 02/14/2025 35,721 $617,616   4.87% 0.09%
JPMORGAN CHASE & CO 02/12/2025 35,470 $613,276   228.06% 0.09%
SWISS NATIONAL BANK 02/10/2025 32,800 $567,112   0.00% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 31,700 $548,093   6.73% 0.08%
BAYBRIDGE CAPITAL GROUP, LLC 01/28/2025 28,563 $493,855   -1.64% 0.07%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/04/2025 28,032 $484,673   -17.39% 0.07%
WCG WEALTH ADVISORS LLC 02/19/2025 24,030 $415,000   6.21% 0.06%

Entrada Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 114 institutional investors and hedge funds held shares of Entrada Therapeutics, Inc.. The most heavily invested institutionals were:

Parallel Advisors, LLC: 0

BAKER BROS. ADVISORS LP: 4.87 M

5AM Venture Management, LLC: 4.41 M

MPM ASSET MANAGEMENT LLC: 4.38 M

PRICE T ROWE ASSOCIATES INC /MD/: 2.9 M

JANUS HENDERSON GROUP PLC: 2.08 M

75.32% of Entrada Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 32.31 M shares in the last 24 months. This purchase volume represents approximately $255.27 M in transactions.